2,6-Di (substitutedamino) purine ribonucleoside analogues and administration to treat respiratory inflammation

PCT No. PCT/EP94/00145 Sec. 371 Date Sep. 18, 1995 Sec. 102(e) Date Sep. 18, 1995 PCT Filed Jan. 18, 1994 PCT Pub. No. WO94/17090 PCT Pub. Date Aug. 4, 1994The present invention relates to 2,6-diaminopurine- beta -D-ribofuranuronamide derivatives of the following formula (I). These compounds and the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KNIGHT, JOHN, ELLIS, FRANK, GREGSON, MICHAEL, EWAN, GEORGE BLANCH, AYRES BARRY EDWARD
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY DERIVATIVES THEREOF HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SUGARS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PCT No. PCT/EP94/00145 Sec. 371 Date Sep. 18, 1995 Sec. 102(e) Date Sep. 18, 1995 PCT Filed Jan. 18, 1994 PCT Pub. No. WO94/17090 PCT Pub. Date Aug. 4, 1994The present invention relates to 2,6-diaminopurine- beta -D-ribofuranuronamide derivatives of the following formula (I). These compounds and their salts and solvates are useful as anti-inflammatory agents, particularly in the treatment of patients with inflammatory conditions who are susceptible to leukocyte-induced tissue damage.